journal
MENU ▼
Read by QxMD icon Read
search

Hepatology International

journal
https://www.readbyqxmd.com/read/30206761/metabolic-effects-of-reduced-growth-hormone-action-in-fatty-liver-disease
#1
Kerstin Rufinatscha, Claudia Ress, Sabrina Folie, Simone Haas, Karin Salzmann, Patrizia Moser, Jochen Dobner, Guenter Weiss, Paula Iruzubieta, María Teresa Arias-Loste, Javier Crespo, Herbert Tilg, Susanne Kaser
BACKGROUND: Adult growth hormone (GH) deficiency is associated with fatty liver disease and shows several features of the metabolic syndrome. Vice versa obesity is characterized as a state of low GH function. Here, we aimed to define the role of hepatic GH signaling and its metabolic consequences in non-alcoholic fatty liver disease. METHODS: In humans, GHR and IGF-1 levels were determined in liver samples of 29 obese patients with non-alcoholic steatohepatitis (NASH) or simple steatosis...
September 11, 2018: Hepatology International
https://www.readbyqxmd.com/read/30203382/approach-and-management-of-dysnatremias-in-cirrhosis
#2
REVIEW
Mauro Bernardi, Giacomo Zaccherini
Hypervolemic (dilutional) hyponatremia is the most common dysnatremia in cirrhosis, with a prevalence close to 50% in patients with ascites, while hypovolemic hyponatremia occurs in a minority of cases. Hyponatremia carries a poor prognosis, being associated with increased mortality and reduced survival after liver transplantation. Hypernatremia is rarer and is also associated with an adverse prognosis. Increased non-osmotic secretion of arginine vasopressin and altered renal tubular sodium handling due to impaired free water generation are the mechanisms leading to hypervolemic hyponatremia, while diuretic-induced fluid loss is the main cause of hypovolemic hyponatremia...
September 10, 2018: Hepatology International
https://www.readbyqxmd.com/read/30203381/tolerable-and-curable-treatment-in-hiv-hcv-co-infected-patients-using-anti-hcv-direct-antiviral-agents-a-real-world-observation-in-china
#3
Yuanyuan Li, Linghua Li, Jun Liu, Da-Wei Zhang, Fang Zhao, Li Wang, Aizezi Mahemure, Ronghui Xie, Suyun Lei, Weiping Cai, Xicheng Wang, Zhanjun Shu, Xiejie Chen, Hui Wang, Fu-Sheng Wang
OBJECTIVE: No brand direct-acting antiviral agents (DAAs) are available for treatment of HIV-1/HCV co-infected patients in China. This study aimed to observe the therapeutic efficacy and safety of generic DAAs for affected Chinese patients. DESIGN: Real-world setting to elucidate whether DAAs were tolerated and effective in HIV-1/HCV co-infected patients. METHODS: 176 HIV-1/HCV co-infected patients received anti-HCV DAA treatment together with ART regimens for HIV infection...
September 10, 2018: Hepatology International
https://www.readbyqxmd.com/read/30182166/serum-ferritin-level-is-associated-with-liver-steatosis-and-fibrosis-in-korean-general-population
#4
Ju Young Jung, Jae-Jun Shim, Sung Keun Park, Jae-Hong Ryoo, Joong-Myung Choi, In-Hwan Oh, Kyu-Won Jung, Hyunsoon Cho, Moran Ki, Young-Joo Won, Chang-Mo Oh
BACKGROUND: Elevation of serum ferritin levels is frequently observed in non-alcoholic fatty liver disease (NAFLD) patients. Our study aims to examine the association between serum ferritin levels and NAFLD in Korean population. METHODS AND RESULTS: A total of 25,597 participants were selected from Korean National Health and Nutritional Examination Surveys 2007-2012. The NAFLD liver fat score (NLFS) was used to define NAFLD. Elevation of ALT levels was defined as ALT level > 40 IU/L for male and ALT level > 31 IU/L for female...
September 4, 2018: Hepatology International
https://www.readbyqxmd.com/read/30132178/single-nucleotide-rs738409-polymorphisms-in-the-pnpla3-gene-are-strongly-associated-with-alcoholic-liver-disease-in-han-chinese-males
#5
REVIEW
Yanfang Zhang, Tongsheng Guo, Funing Yang, Yuanli Mao, Liubing Li, Chenxi Liu, Qiang Sun, Yongzhe Li, Jing Huang
OBJECTIVE: Alcoholic liver disease (ALD) is a chronic liver disorder caused by the consumption of large amounts of alcohol. Genome-wide association studies have recently confirmed that polymorphisms in PNPLA3 predispose individuals to ALD and have identified risk loci of MBOAT7 and TM6SF2 in persons of European descent. However, the association with alcoholic liver damage has not been evaluated thus far in a Han Chinese population. METHODS: We performed a large case-control multicenter study of 507 ALD patients and 645 ethnically matched healthy controls...
August 21, 2018: Hepatology International
https://www.readbyqxmd.com/read/30116993/management-of-acute-on-chronic-liver-failure-an-algorithmic-approach
#6
Shiv Kumar Sarin, Ashok Choudhury
Acute-on-chronic liver failure (ACLF) is a distinct syndrome of liver failure in a patient with chronic liver disease presenting with jaundice, coagulopathy and ascites and/or hepatic encephalopathy, developing following an acute hepatic insult and associated with high 28-day mortality. The definition though lacks global consensus, excludes patients with known distinct entities such as acute liver failure and those with end-stage liver disease. The initial Systemic Inflammatory Response Syndrome (SIRS) because of cytokine storm in relation to acute insult and/or subsequent development of sepsis due to immunoparalysis leads to extrahepatic organ failure...
August 16, 2018: Hepatology International
https://www.readbyqxmd.com/read/30088198/multiple-doses-of-hepatitis-b-recombinant-vaccine-for-chronic-hepatitis-b-patients-with-low-surface-antigen-levels-a-pilot-study
#7
Ming-Wei Lai, Chao-Wei Hsu, Chih-Lang Lin, Rong-Nan Chien, Wey-Ran Lin, Chi-Sheng Chang, Kung-Hao Liang, Chau-Ting Yeh
BACKGROUND: Seroclearance of hepatitis B surface antigen (HBsAg) has been rarely achieved in the treatment of chronic hepatitis B (CHB) patients. We administered HBsAg-based recombinant vaccine in patients with low HBsAg concentrations. METHODS: Twenty hepatitis B e antigen-negative patients, with HBsAg < 1000 IU/ml, were enrolled. Vaccines were administered every 8 weeks for 48 weeks (seven doses). HBsAg levels and anti-HBs were assayed longitudinally until 48 weeks post-vaccination...
August 7, 2018: Hepatology International
https://www.readbyqxmd.com/read/30073454/liver-resection-versus-transarterial-chemoembolization-for-the-initial-treatment-of-barcelona-clinic-liver-cancer-stage-b-hepatocellular-carcinoma
#8
REVIEW
Biao Yang, Bo Zheng, MaoNan Yang, Zhu Zeng, FangYun Yang, Ji Pu, ChunLin Li, ZhengYin Liao
AIMS: Current evidence supporting the efficacy of transarterial chemoembolization (TACE) in Barcelona Clinic Liver Cancer (BCLC)-B hepatocellular carcinoma (HCC) is controversial. The aim of this systematic review was to compare the benefits of liver resection (LR) versus TACE in BCLC-B HCC. METHODS: We conducted a comprehensive literature review of the EMBASE, PubMed, Google Scholar, and Chinese Biomedical Literature databases for retrospective or prospective studies evaluating the efficacy of LR and TACE for the treatment of BCLC-B HCC...
August 2, 2018: Hepatology International
https://www.readbyqxmd.com/read/30066204/algorithms-for-managing-coagulation-disorders-in-liver-disease
#9
REVIEW
R Todd Stravitz
Patients with advanced liver disease have traditionally been considered at risk for bleeding complications. However, although bleeding in patients with cirrhosis frequently occurs due to complications of portal hypertension, research performed within the last 15 years has increasingly shown that hemostasis in patients with liver failure generally achieves a state of "rebalance", whereby compensatory systems restore a relatively neutral or even slightly pro-thrombotic state. Much recent clinical and in vitro research has, in fact, shown over-compensation, such that patients with acute and stable chronic liver failure may have a thrombotic tendency, which may participate in the progression of liver disease and cause systemic and portal thrombosis...
July 31, 2018: Hepatology International
https://www.readbyqxmd.com/read/30043328/clinical-implication-and-viral-mutation-in-basal-core-promoter-pre-core-of-hepatitis-b-virus-c-d-recombinant
#10
Hua Li, Qilu She, Yu Liu, Yuehe Ding, Shenghua Shi, Jijie Li, Hongkai Wu, Zhanhui Wang
BACKGROUND AND AIM: Hepatitis B virus (HBV) C/D recombinant is predominant in Tibet in Western China. Although the geographical and ethnic distributions of the C/D recombinant have been described, the clinical implication and the characteristics of viral mutation in the basal core promoter (BCP)/pre-core (PC) region remain unclear. METHODS: A total of 174 chronic HBV carriers, including 115 with chronic hepatitis B, 45 with liver cirrhosis, and 14 with hepatocellular carcinoma, were enrolled...
July 24, 2018: Hepatology International
https://www.readbyqxmd.com/read/29992512/hepatitis-c-virus-genotype-4-infection-and-interferon-free-treatment-in-egypt
#11
EDITORIAL
Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama
No abstract text is available yet for this article.
July 10, 2018: Hepatology International
https://www.readbyqxmd.com/read/29974410/non-alcoholic-hepatic-steatosis-attenuates-hepatitis-b-virus-replication-in-an-hbv-immunocompetent-mouse-model
#12
Danqing Hu, Hongwu Wang, Hai Wang, Yaqi Wang, Xiaoyang Wan, Weiming Yan, Xiaoping Luo, Qin Ning
OBJECTIVE: The relationship between chronic hepatitis B virus (HBV) infection and fatty liver in patients remains unclear. Although high-fat diets-induced hepatic steatosis was proved to reduce HBV replication in transgenic mice, the interplay between HBV and fatty liver in immunocompetent mouse model is yet to be elucidated. Here, we aimed to develop an effective animal model for intracellular HBV persistence combined with hepatic steatosis and to explore their interactions. METHODS: FVB/N mice with HBV genotype B replicon DNA were established by hydrodynamic injection...
July 5, 2018: Hepatology International
https://www.readbyqxmd.com/read/29971683/budd-chiari-syndrome-has-different-presentations-and-disease-severity-during-adolescence
#13
Akash Shukla, Pratin Bhatt, Deepak Kumar Gupta, Tejas Modi, Jatin Patel, Amit Gupte, Megha Meshram, Shobna Bhatia
There are limited data on clinical profile of adolescent patients with Budd-Chiari syndrome (BCS). We studied clinical, radiological, thrombophilia profile and treatment outcomes in adolescent patients with BCS. METHODS: Forty-three consecutive patients of BCS with onset of symptoms during adolescence (10-19 years) were enrolled in the study. 129 randomly selected adult patients with BCS and 36 children with BCS formed the two control groups. The clinical history, physical examination, laboratory tests, thrombophilic disorders, radiological features and treatment outcomes of adolescents were compared to adults and children...
July 3, 2018: Hepatology International
https://www.readbyqxmd.com/read/30054801/global-hbv-burden-guesstimates-and-facts
#14
REVIEW
Dina Ginzberg, Robert J Wong, Robert Gish
Chronic hepatitis B virus infection (HBV) continues to pose a serious global health threat in many areas of the world, particularly in sub-Saharan Africa, the Western Pacific Region and areas of Eastern Europe. Endemicity is heterogeneous within and across regions owing to variable implementation of childhood and birth-dose vaccination programs, inconsistent screening of blood products, injection drug use, and poor education initiatives. This review aims to provide comprehensive up-to-date estimates of global seroprevalence of chronic HBV across six World Health Organization (WHO) regions, noting patterns of change over time and highlighting potential region-specific barriers to the diagnosis and elimination of HBV...
July 2018: Hepatology International
https://www.readbyqxmd.com/read/30030720/sofosbuvir-velpatasvir-plus-ribavirin-in-japanese-patients-with-genotype-1-or-2-hepatitis-c-who-failed-direct-acting-antivirals
#15
Namiki Izumi, Tetsuo Takehara, Kazuaki Chayama, Hiroshi Yatsuhashi, Koichi Takaguchi, Tatsuya Ide, Masayuki Kurosaki, Yoshiyuki Ueno, Hidenori Toyoda, Satoru Kakizaki, Yasuhito Tanaka, Yoshiiku Kawakami, Hirayuki Enomoto, Fusao Ikeda, Deyuan Jiang, Shampa De-Oertel, Brian L McNabb, Gregory Camus, Luisa M Stamm, Diana M Brainard, John G McHutchison, Satoshi Mochida, Masashi Mizokami
BACKGROUND/PURPOSE: In Japan, there is a growing population of patients with chronic hepatitis C virus (HCV) infection who failed a direct-acting antiviral (DAA)-based regimen. In this Phase 3 study, we evaluated sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 HCV infection who previously received DAAs. METHODS: Patients were randomized 1:1 to receive sofosbuvir-velpatasvir plus ribavirin for 12 or 24 weeks. Randomization was stratified by HCV genotype and presence of cirrhosis...
July 2018: Hepatology International
https://www.readbyqxmd.com/read/30027532/linking-the-gut-and-liver-crosstalk-between-regulatory-t-cells-and-mucosa-associated-invariant-t-cells
#16
REVIEW
Muhammad Atif, Suz Warner, Ye H Oo
The gut-liver axis is increasingly considered to play a vital part in the progression of chronic inflammatory gut and liver diseases. Hence, a detailed understanding of the local and systemic regulatory mechanisms is crucial to develop novel therapeutic approaches. In this review, we discuss in-depth the roles of regulatory T cells (Tregs) and mucosal-associated invariant T cells (MAITs) within the context of inflammatory bowel disease, primary sclerosing cholangitis, and non-alcoholic steatohepatitis. Tregs are crucial in maintaining peripheral tolerance and preventing autoimmunity...
July 2018: Hepatology International
https://www.readbyqxmd.com/read/29947010/impact-of-viral-hepatitis-b-status-on-outcomes-of-intrahepatic-cholangiocarcinoma-a-meta-analysis
#17
REVIEW
Seogsong Jeong, Guijuan Luo, Zhi-Heng Wang, Meng Sha, Lei Chen, Qiang Xia
BACKGROUND AND AIMS: To estimate the impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma. METHODS: We searched Pubmed and Embase for original articles that evaluated the impact of hepatitis B virus infection on outcomes of intrahepatic cholangiocarcinoma. The present study was conducted to generate odd ratios (ORs) with 95% confidence intervals (CIs) for pre-identified prognostic factors, overall survival, and recurrence. RESULTS: From 438 studies, we identified eight articles that compared outcomes between hepatitis B virus-infected patients and the others...
July 2018: Hepatology International
https://www.readbyqxmd.com/read/29860678/evaluation-of-liver-function-using-gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic-acid-enhanced-magnetic-resonance-imaging-based-on-a-three-dimensional-volumetric-analysis-system
#18
Masashi Kudo, Naoto Gotohda, Motokazu Sugimoto, Tatsushi Kobayashi, Motohiro Kojima, Shinichiro Takahashi, Masaru Konishi, Ryuichi Hayashi
BACKGROUND: Magnetic resonance imaging with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (EOB-MRI) is a diagnostic modality for liver tumors. Three-dimensional (3D) volumetric analysis systems using EOB-MRI data are used to simulate liver anatomy for surgery. This study was conducted to investigate clinical utility of a 3D volumetric analysis system on EOB-MRI to evaluate liver function. METHODS: Between August 2014 and December 2015, 181 patients underwent laboratory and radiological exams as standardized preoperative evaluation for liver surgery...
July 2018: Hepatology International
https://www.readbyqxmd.com/read/29663115/sofosbuvir-plus-daclatasvir-with-or-without-ribavirin-for-treatment-of-chronic-hcv-genotype-4-patients-real-life-experience
#19
G Shiha, R Soliman, M ElBasiony, A A Hassan, N N H Mikhail
INTRODUCTION: New regimens involving direct-acting antiviral agents have recently been approved for the treatment of HCV. Our aim was to assess the efficacy and safety of 12 or 24 weeks of Sofosbuvir 400 mg plus Daclatasvir 60 mg, with or without ribavirin (800-1000 mg) in treating chronic hepatitis C genotype 4 patients. METHODS: This is an open-label observational study that describes the effect of 12 week or 24 weeks of daily oral Sofosbuvir (SOF) 400 mg plus Daclatasvir (DCV) 60 mg with or without ribavirin (RBV) with dose adjustment if indicated...
July 2018: Hepatology International
https://www.readbyqxmd.com/read/29931590/depression-fatigue-and-neurocognitive-deficits-in-chronic-hepatitis-c
#20
REVIEW
Sern Wei Yeoh, Alex C N Holmes, Michael M Saling, Ian P Everall, Amanda J Nicoll
Patients with chronic hepatitis C virus (HCV) infection experience a range of symptoms including depression, fatigue and neurocognitive deficits, impairing quality of life. Depression, in particular, may be reactive to increased psychosocial stress, and the physical symptoms of advanced HCV or associated comorbidities. However, even patients at an early stage of HCV infection, with minimal hepatic inflammation or comorbidities, report more depressive symptoms and fatigue than the general population. Similarly, specific neurocognitive deficits occur in early stage HCV infection and are independent of the presence of depression or encephalopathy...
June 21, 2018: Hepatology International
journal
journal
41620
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"